assess
risk
infect
emerg
virus
exist
virus
jump
speci
barrier
novel
host
limit
lack
dose
respons
data
initi
stage
infect
host
viru
involv
seri
specif
contact
interact
molecul
host
viru
surfac
strength
interact
quantifi
literatur
dissoci
constant
k
determin
experiment
specif
given
viru
moleculehost
molecul
combin
two
stage
initi
infect
process
host
intestin
cell
model
name
escap
viru
oral
challeng
dose
innat
host
defens
eg
mucin
protein
mucu
subsequ
bind
surviv
viru
receptor
molecul
surfac
host
epitheli
cell
strength
viru
bind
host
cell
mucin
may
quantifi
associ
constant
k
k
mucin
respect
mechanist
doserespons
model
probabl
infect
host
given
viru
dose
construct
use
k
k
mucin
may
deriv
publish
k
valu
take
account
number
specif
molecular
interact
shown
effect
mucu
barrier
determin
amount
mucin
also
magnitud
k
mucin
high
k
mucin
valu
slight
excess
mucin
viru
suffici
remov
viru
accord
model
lower
k
mucin
valu
high
number
viru
may
escap
even
larg
excess
mucin
output
mechanist
model
probabl
p
infect
singl
virion
paramet
use
convent
doserespons
model
predict
risk
infect
host
ingest
dose
shown
differ
k
due
molecular
differ
emerg
viru
strain
new
host
affect
p
differ
k
may
quantifi
term
two
thermodynam
paramet
name
enthalpi
entropi
provid
theoret
link
sequenc
data
risk
infect
lack
data
entropi
limit
present
may
also
affect
interpret
k
term
infect
conclud
thermodynam
approach
major
contribut
make
develop
doserespons
model
emerg
virus
microbiolog
risk
assess
mra
requir
doserespons
relationship
translat
exposur
ie
number
pathogen
particl
enter
host
given
rout
probabl
infect
infect
oral
pathogen
defin
multipl
organ
within
host
follow
excret
haa
et
al
purpos
work
includ
progress
diseas
host
acquir
immun
respons
obtain
doserespons
data
human
gener
reli
volunt
challeng
experi
eg
cryptosporidium
parvum
student
okhuysen
et
al
use
outbreak
data
backcalcul
relationship
measur
exposur
infect
rate
teuni
et
al
limit
approach
particularli
emerg
pathogen
exposur
rout
may
fulli
elucid
pathogen
seriou
clinic
outcom
eg
zair
ebolaviru
ebov
furthermor
zoonot
virus
emerg
jump
speci
barrier
anim
sourc
human
eg
nipah
viru
niv
ebov
respect
dose
respons
would
oneoff
event
may
ineffici
difficult
reproduc
without
larg
number
anim
addit
complic
pathogen
may
adapt
new
host
infect
increas
well
establish
filovirus
laboratori
anim
infect
per
plaqueform
unit
pfu
may
chang
sever
order
magnitud
passag
gale
et
al
recent
demonstr
ebov
makona
adapt
human
amino
acid
substitut
glycoprotein
recent
catastroph
outbreak
west
africa
diehl
et
al
urbanowicz
et
al
outbreak
also
rais
mani
question
regard
unknown
potenti
companion
anim
cat
dog
serv
either
reservoir
vector
viru
involv
transmiss
ebov
human
anim
absenc
doserespons
data
ebov
human
limit
develop
mra
risk
infect
citizen
eu
exampl
ebov
illeg
import
bushmeat
inde
propos
infect
human
ebov
pfu
may
differ
bushmeat
sampl
differ
wildlif
speci
eg
fruit
bat
nonhuman
primat
also
differ
individu
speci
depend
degre
host
adapt
gale
et
al
effect
two
piec
bushmeat
ebovinfect
wildlif
may
term
infect
human
although
remain
prove
clearli
need
novel
approach
calibr
doserespons
relationship
purpos
mra
emerg
pathogen
infect
process
host
cell
broken
compon
step
model
mathemat
handel
et
al
probabl
infect
express
function
combin
probabl
step
gale
et
al
step
includ
overcom
initi
host
defens
bind
virion
host
cell
receptor
entri
host
cell
ie
internalis
uncoat
virion
replic
capsid
assembl
bud
gale
et
al
previous
demonstr
doserespons
model
could
part
parameter
use
thermodynam
data
key
molecular
interact
infect
process
gale
beauti
thermodynam
data
measur
experiment
biochemist
case
use
molecular
compon
eg
clone
viru
protein
host
receptor
protein
wang
et
al
involv
live
anim
human
volunt
studi
major
advantag
danger
pathogen
furthermor
effect
amino
acid
substitut
host
receptor
bind
affin
measur
directli
yuan
et
al
possibl
appli
thermodynam
develop
two
key
step
infect
process
host
viru
first
step
model
probabl
viru
overcom
innat
host
defens
pose
mucin
protein
molecul
pathogen
recognit
receptor
prr
produc
host
mucin
sugar
unit
surfac
bind
compon
surfac
viru
exampl
haemagglutinnin
ha
glycoprotein
molecul
influenza
viru
de
graaf
fouchier
noroviru
nov
de
rougemont
et
al
mucu
present
respiratori
tract
hamper
influenza
viru
infect
case
human
predominantli
contain
acid
receptor
inde
influenza
virus
specif
inhibit
human
mucin
de
graaf
fouchier
prr
includ
mannos
bind
protein
mbp
carbohydraterecognit
domain
crd
bind
regularli
repeat
sugar
unit
pathogen
surfac
taylor
drickam
second
step
model
bind
viru
specif
receptor
host
cell
surfac
approach
develop
gener
faecalor
viru
nov
rotaviru
infect
epitheli
cell
line
intestin
boshuizen
et
al
de
rougemont
et
al
could
appli
influenza
virus
inhal
infect
cell
trachea
lung
de
graaf
fouchier
paper
first
give
overview
mechanist
dose
respons
model
introduc
two
probabl
paramet
name
fraction
f
v
viru
escap
mucin
defens
barrier
fraction
f
c
host
cell
bound
viru
method
section
set
differ
equat
method
model
f
v
f
c
function
mucin
viru
ratio
viru
dose
intestin
respect
central
determin
f
v
f
c
strength
bind
viru
mucin
host
cell
defin
equilibrium
constant
k
mucin
k
respect
theori
section
applic
publish
data
bind
viru
surfac
envelop
glycoprotein
gp
host
cell
receptor
cr
molecul
mucin
molecul
review
term
determin
k
mucin
k
order
parameter
doserespons
particular
refer
made
use
dissoci
constant
k
routin
determin
experiment
viru
gp
bind
cr
molecul
gambaryan
et
al
raman
et
al
yuan
et
al
shown
strength
virushost
cell
bind
ie
magnitud
k
may
predict
chang
two
thermodynam
paramet
name
enthalpi
h
entropi
effect
amino
acid
chang
contact
surfac
viru
gp
cr
enthalpi
consid
view
futur
parameter
doserespons
model
base
genet
sequenc
data
entropi
chang
also
consid
term
viru
bind
also
interpret
k
data
model
paramet
variabl
summaris
tabl
ingest
initi
viru
challeng
dose
v
initi
host
number
immedi
host
defenc
mouth
gastrointestin
gi
tract
includ
mucu
barrier
decoy
receptor
innat
immun
system
select
bind
henc
remov
viru
mcguckin
et
al
exampl
histoblood
group
antigen
hbga
genet
determin
glycan
nov
select
bind
present
decoy
receptor
saliva
mucin
main
protein
compon
mucu
shanker
et
al
total
number
virus
surviv
mucin
barrier
get
intestin
given
f
v
fraction
free
viru
ie
bound
mucin
shown
fig
f
v
model
two
paramet
name
total
number
muc
total
mucin
molecul
mucu
saliva
gi
tract
associ
constant
k
mucin
defin
quantifi
strength
bind
viru
mucin
molecul
thu
insert
f
v
fig
given
mucin
concentr
eq
total
number
free
viru
particl
intestin
avail
initi
infect
epithelium
may
model
reach
intestin
epithelium
free
viru
particl
bind
surfac
host
cell
probabl
infect
host
p
host
equal
probabl
success
infect
least
one
cell
relat
number
cell
cv
bound
viru
p
cell
probabl
success
infect
host
cell
given
viru
bound
surfac
thu
cell
bound
viru
greater
chanc
infect
success
least
one
probabl
p
cell
depend
abil
bound
viru
enter
cell
replic
bud
gale
et
al
gale
discuss
f
c
fraction
cell
bound
viru
c
total
number
cell
host
intestin
epithelium
shown
fig
f
c
directli
proport
total
number
viru
particl
intestin
v
intestin
also
depend
strength
bind
interact
viru
epitheli
cell
surfac
quantifi
associ
constant
k
defin
express
fraction
f
v
virus
bound
mucu
fraction
f
c
host
cell
bound
viru
term
associ
constant
k
mucin
k
bind
process
repres
dynam
equilibrium
thu
within
given
volum
intestin
free
viru
v
free
host
cell
bound
viru
c
free
dynam
equilibrium
cell
bound
viru
cv
repres
associ
constant
k
express
term
concentr
gale
squar
bracket
repres
concentr
mole
dm
term
dynam
equilibrium
mean
process
revers
handel
et
al
free
viru
bind
free
host
cell
form
cv
rate
k
cv
complex
dissoci
c
free
v
free
slower
rate
k
depend
strength
bind
thu
associ
constant
k
similarli
k
mucin
may
also
written
term
associationdissoci
rate
visualis
k
k
mucin
term
onoff
rate
may
easier
conceptu
implic
host
viru
factor
select
chang
k
k
see
thu
affect
k
k
mucin
accord
eq
shown
gale
fraction
f
c
host
cell
fraction
f
v
viru
bound
mucin
plot
function
total
mucin
total
viru
ratio
viru
challeng
dose
dm
volum
intestin
fix
viru
particl
number
mucin
molecul
increas
molecul
repres
symbol
bind
viru
achiev
horizont
dot
line
repres
unbound
viru
remain
intestin
solid
line
symbol
repres
point
calcul
differ
equat
approach
see
text
k
mucin
valu
x
dash
line
repres
eq
assum
muc
total
muc
free
k
mucin
valu
left
right
eq
fail
high
k
mucin
valu
mucin
viru
ratio
arrow
bound
viru
given
c
free
substitut
cv
eq
rearrang
give
f
c
term
free
viru
concentr
v
free
k
similarli
viru
enter
host
dynam
equilibrium
viru
bound
mucin
henc
reach
intestin
epithelium
v
intestin
free
mucin
muc
free
viru
bound
mucin
vmuc
strength
bind
reflect
associ
constant
k
mucin
viru
mucin
express
fraction
free
viru
f
v
given
replac
vmuc
eq
rearrang
give
f
v
term
free
mucin
concentr
k
mucin
object
construct
plot
f
c
function
v
intestin
shown
fig
eq
may
use
v
free
repres
v
intestin
total
number
viru
particl
v
intestin
greatli
exce
number
host
cell
c
total
v
free
rel
unaffect
viru
bind
therefor
v
free
approxim
v
intestin
also
accept
low
bind
affin
virus
speci
barrier
model
gale
littl
viru
bound
even
high
viru
dose
howev
mani
natur
infect
process
eg
drink
water
host
may
challeng
low
number
pathogen
bind
high
affin
host
cell
v
free
greatli
diminish
compar
v
intestin
tend
zero
viru
bound
problem
eq
express
mathemat
term
v
intestin
solut
adopt
model
f
c
term
v
intestin
compris
three
step
first
step
involv
set
model
host
intestin
concentr
viru
host
cell
may
defin
order
calcul
k
use
eq
second
step
differ
equat
approach
use
produc
rang
v
free
c
free
cv
combin
six
differ
total
viru
v
intestin
dose
concentr
k
valu
f
c
valu
calcul
plot
fig
third
step
six
v
intestin
dose
f
c
read
fig
given
k
valu
f
c
plot
v
intestin
k
fig
develop
doserespons
model
base
k
k
mucin
requir
estim
volum
dm
ie
litr
within
challeng
dose
pathogen
access
suscept
cell
host
need
convert
particl
number
mole
concentr
use
eq
volum
pathogen
enter
within
host
exampl
lumen
intestin
even
drop
bodi
fluid
eg
blood
mucos
surfac
case
ebov
purpos
model
cm
length
host
intestin
radiu
cm
simul
total
surfac
area
therefor
cm
volum
insid
intestin
lumen
dm
dm
cm
accord
rosen
misfeldt
densiti
cell
dog
kidney
epithelia
cell
per
cm
total
number
c
total
epitheli
cell
cm
surfac
model
intestin
thu
densiti
cell
volum
per
dm
divid
avogadro
number
l
particl
per
mole
price
dwek
give
mole
concentr
volum
c
total
total
host
cell
reassur
note
similar
cell
concentr
report
canin
kidney
cell
avian
influenza
viru
bind
experi
nunescorreia
et
al
handel
et
al
simul
influenza
viru
infect
use
concentr
higher
although
simpli
assum
pack
collect
cell
volum
model
therefor
take
account
larg
void
volum
intestin
within
faecalor
pathogen
dilut
simul
undertaken
six
viru
dose
v
intestin
virion
model
intestin
fig
repres
viru
host
cell
ratio
concentr
differ
equat
approach
model
f
c
k
viru
dose
fig
low
viru
dose
ie
v
intestin
c
total
k
calcul
use
cv
v
free
c
free
eq
full
rang
viru
bind
ie
one
bound
viru
v
intestin
virus
bound
accord
eq
cell
bind
one
viru
number
cell
bound
viru
therefor
equal
number
virus
bound
cell
calcul
rang
v
free
virus
bound
v
intestin
virus
bound
high
viru
dose
ie
v
intestin
c
total
simul
run
v
free
c
total
cv
alway
posit
model
eq
assum
cell
bind
one
viru
cv
number
free
cell
c
free
calcul
valu
c
free
v
free
cv
calcul
c
free
v
free
cv
respect
divid
volum
intestin
dm
l
use
calcul
k
eq
rang
cv
viru
challeng
dose
valu
f
c
plot
function
k
microbi
risk
analysi
fig
f
c
calcul
c
total
c
total
constant
cell
tabl
fraction
free
viru
f
v
repres
probabl
viru
bound
mucin
effect
escap
mucin
barrier
object
model
f
v
function
mucin
viru
ratio
rang
k
mucin
valu
shown
fig
simpl
approach
model
f
v
use
eq
muc
free
repres
total
concentr
mucin
intestin
muc
total
measur
host
experiment
discuss
fail
mucin
viru
ratio
therefor
differ
equat
approach
use
challeng
dose
v
initi
host
intestin
fix
virion
fraction
viru
bound
mucin
f
v
calcul
ten
valu
muc
total
rang
mucin
molecul
mucin
molecul
repres
mucin
viru
ratio
rang
done
use
stage
describ
viru
bind
host
cell
seven
k
mucin
valu
rang
thu
number
free
mucin
molecul
muc
free
rang
ie
mucin
molecul
bound
viru
muc
total
ie
mucin
molecul
free
viru
valu
vmuc
v
intestin
calcul
divid
volum
intestin
l
valu
vmuc
v
intestin
muc
free
convert
correspond
concentr
name
vmuc
v
intestin
muc
free
k
mucin
valu
calcul
use
eq
k
mucin
valu
f
v
calcul
plot
shown
f
v
versu
k
mucin
construct
viru
bind
host
cell
fig
plot
valu
f
v
ten
muc
total
read
given
k
mucin
plot
mucin
molecul
viru
ratio
ie
muc
total
v
initi
fig
stochast
challeng
dose
v
initi
would
address
exposur
calcul
outsid
scope
work
mechanist
doserespons
model
develop
use
differ
equat
approach
affect
stochast
valu
cv
v
intestin
calcul
eq
respect
given
integ
thu
f
c
f
v
calcul
eq
respect
exact
integ
cv
v
intestin
c
total
v
initi
constant
integ
simul
probabl
infect
host
accord
eq
calcul
integ
valu
cv
c
total
v
intestin
depend
lower
affect
stochast
effect
stochast
consid
use
eq
calcul
f
c
cv
fraction
model
assum
free
pathogen
mucin
homogen
distribut
within
lumen
intestin
concentr
equilibrium
constant
along
length
simul
intestin
spatial
heterogen
pathogen
lumen
known
could
vari
depend
pathogen
distribut
food
water
faecalvomit
contamin
ingest
host
exampl
ingest
small
amount
faec
laden
viru
could
give
much
higher
viru
concentr
certain
part
lumen
depend
degre
mix
within
lumen
contrast
ingest
dm
volum
water
contamin
pathogen
could
give
homogen
poisson
distribut
along
length
consid
spatial
heterogen
exist
mucin
concentr
mucu
form
layer
line
intestin
wall
mcguckin
et
al
need
consider
develop
mechanist
approach
intestin
simul
intern
volum
dm
total
suscept
cell
intestin
epithelium
fig
oral
challeng
dose
virus
administ
fraction
escap
mucin
barrier
reach
epithelium
model
fig
show
fraction
epithelium
cell
bound
viru
function
k
six
dose
viru
got
mucin
barrier
rang
virion
virion
fig
point
fig
replot
form
doserespons
relat
fraction
host
cell
bound
viru
dose
viru
got
mucin
barrier
doserespons
relationship
present
rang
k
valu
fig
fraction
f
v
viru
escap
mucu
barrier
plot
function
mucin
viru
ratio
rang
k
mucin
valu
fig
horizont
dot
line
fig
repres
one
free
viru
remain
dm
volum
simul
intestin
valu
f
v
line
free
viru
simul
intestin
effect
virion
initi
challeng
dose
v
initi
bound
mucin
thu
effect
mucin
barrier
assess
simpli
term
k
mucin
mucin
viru
ratio
requir
bring
f
v
line
fig
high
k
mucin
valu
viru
bound
mucin
viru
ratio
exce
howev
progress
lower
k
mucin
valu
less
less
viru
bound
given
mucin
viru
ratio
thu
even
k
mucin
valu
high
larg
number
virus
respect
still
free
mucin
viru
ratio
accord
model
fig
dm
volum
simul
intestin
larg
excess
mucin
viru
need
make
signific
impact
fraction
free
viru
lower
k
mucin
valu
exampl
k
mucin
valu
viru
free
respect
mucin
viru
ratio
thu
mop
viru
rel
ineffici
except
high
k
mucin
valu
larg
number
viru
may
break
reflect
dilut
larg
volum
simul
intestin
main
conclus
fig
mucin
viru
ratio
increas
ie
go
left
right
along
xaxi
high
k
mucin
valu
fraction
free
viru
fall
dramat
nonlinearli
viru
mop
k
mucin
expect
mucin
viru
ratio
fraction
free
viru
approach
even
high
k
mucin
valu
fig
simpli
reflect
fact
enough
mucin
capac
mop
viru
high
viru
challeng
dose
overwhelm
mucin
barrier
high
k
mucin
valu
slight
excess
mucin
viru
suffici
mop
viru
intermedi
k
mucin
valu
mop
last
remain
virus
less
effici
proportion
higher
mucin
viru
ratio
requir
lower
k
mucin
valu
simplifi
approach
use
eq
model
f
v
mra
total
mucin
total
viru
ratio
also
express
concentr
total
mucin
muc
total
xaxi
scale
fig
rel
viru
concentr
intestin
fix
thu
viru
particl
volum
dm
divid
l
repres
concentr
dash
line
fig
show
f
v
calcul
eq
k
mucin
valu
use
muc
total
approxim
muc
free
appropri
approxim
high
mucin
viru
ratio
howev
mucin
viru
ratio
muc
free
becom
much
less
muc
total
mucin
bound
particularli
high
k
mucin
valu
eq
applic
exampl
arrow
fig
show
eq
predict
viru
free
ie
viru
bound
viru
particl
mucin
molecul
clearli
possibl
lower
k
mucin
valu
f
v
decreas
linearli
increas
mucin
viru
ratio
may
model
eq
good
agreement
f
v
calcul
differ
equat
approach
symbol
fig
thu
eq
hold
low
k
mucin
valu
high
mucin
viru
ratio
irrespect
k
mucin
import
high
mucin
viru
ratio
might
expect
natur
infect
situat
even
high
viru
challeng
dose
use
simul
practic
point
develop
mra
methodolog
appli
eq
easier
complic
differ
equat
approach
develop
symbol
fig
thu
understand
limit
eq
import
summari
eq
fail
mucin
viru
ratio
higher
k
mucin
valu
repres
arrow
gener
applic
lower
k
mucin
valu
particularli
higher
mucin
viru
ratio
result
show
valu
k
mucin
critic
determin
whether
eq
use
mra
also
assess
effect
mucin
barrier
mop
virus
fraction
host
cell
bound
viru
increas
linearli
dose
viru
simul
intestin
k
valu
high
viru
dose
host
cell
becom
satur
f
c
viru
fig
low
k
valu
unrealist
high
viru
dose
requir
satur
host
cell
fig
f
c
increas
linearli
k
given
viru
dose
surprisingli
limit
viru
dose
v
intestin
c
total
ratio
thu
cell
simul
intestin
viru
dose
virion
maximum
valu
achiev
f
c
respect
virion
bound
k
valu
bind
strong
virion
dose
bound
fig
f
c
reach
plateau
v
intestin
c
total
ratio
ie
dose
fig
repres
v
intestin
c
total
ratio
respect
satur
host
cell
occur
high
k
valu
progress
lower
k
valu
requir
satur
host
cell
viru
dose
increas
thu
increas
k
certain
valu
effect
f
c
either
virus
bound
low
viru
dose
ie
v
intestin
c
total
ratio
host
cell
satur
high
viru
dose
ie
v
intestin
c
total
ratio
born
fig
show
k
valu
doserespons
curv
superimpos
f
c
limit
avail
dose
k
main
conclus
fig
valu
k
rang
critic
affect
f
c
simplifi
approach
use
eq
model
f
c
mra
total
viru
dose
intestin
v
intestin
may
approxim
v
free
convert
concentr
use
v
free
eq
calcul
f
c
altern
differ
equat
approach
use
construct
fig
howev
simplif
fail
k
valu
greater
result
shown
eq
overestim
f
c
order
magnitud
low
viru
dose
result
show
eq
appropri
calcul
f
c
k
valu
least
irrespect
dose
applic
model
demonstr
tabl
four
scenario
repres
differ
combin
initi
challeng
dose
affin
viru
cell
determin
k
thu
k
low
affin
bind
viru
high
affin
bind
viru
broadli
reflect
measur
experiment
nunescorreia
et
al
low
bind
high
affin
bind
site
influenza
viru
bind
canin
kidney
cell
tabl
also
discuss
differ
k
could
reflect
result
singl
amino
acid
chang
gp
cr
molecul
affect
salt
bridg
gpcr
interfac
purpos
demonstr
p
cell
assum
ie
cell
bound
viru
chanc
success
infect
scenario
predict
probabl
host
infect
p
host
rang
f
v
constant
tabl
calcul
use
eq
k
mucin
eq
appropri
muc
free
valu
muc
free
calcul
use
mucin
mass
concentr
mgml
saliva
kejriw
et
al
dilut
factor
food
water
matrix
mucin
protein
molecular
weight
dalton
kesim
sheehan
sole
calcul
demonstr
purpos
tabl
absenc
publish
data
f
c
tabl
vari
scenario
calcul
use
eq
v
free
calcul
v
intestin
dm
volum
simul
intestin
l
valu
k
use
scenario
low
enough
eq
applic
see
seen
k
line
differ
equat
approach
fig
f
c
v
intestin
virion
agreement
tabl
approach
use
f
c
eq
predict
fraction
cv
tabl
low
dose
scenario
also
high
dose
low
affin
scenario
realiti
cv
must
integ
differ
equat
approach
issu
stochast
aris
model
tabl
demonstr
applic
mechanist
doserespons
model
predict
probabl
infect
host
p
host
initi
challeng
dose
v
initi
low
high
affin
bind
viru
tabl
cv
fraction
investig
effect
stochast
mechanist
model
develop
tabl
use
determin
infecti
dose
id
ie
valu
v
initi
p
host
found
high
affin
viru
k
id
virus
low
affin
viru
k
id
virus
tabl
cv
valu
id
much
greater
rang
stochast
less
issu
classic
dose
respons
model
infect
host
written
p
risk
infect
ingest
singl
virion
host
rearrang
eq
set
v
initi
id
p
host
p
calcul
high
affin
low
affin
virus
respect
valu
may
use
directli
convent
doserespons
model
form
eq
furthermor
set
v
initi
mechanist
model
tabl
predict
probabl
valu
high
affin
low
affin
virus
respect
suggest
stochast
problem
expect
doserespons
model
linear
low
dose
valu
p
host
also
calcul
tabl
use
p
obtain
mechanist
model
describ
directli
eq
estim
risk
initi
challeng
dose
v
initi
result
ident
predict
mechanist
method
larg
neg
see
henc
lower
magnitud
k
k
calcul
k
n
use
eq
n
k
k
n
k
k
assum
jmolk
approach
calcul
k
enthalpi
entropi
term
enthalpi
term
favour
interact
eg
format
salt
bridg
amino
acid
residu
gpcr
contact
interfac
good
spatial
fit
give
larg
neg
valu
drive
viru
bind
limit
lack
specif
data
gpcr
contact
virushost
cell
bind
kjmol
antibodi
bind
antigen
bostrom
et
al
kjmol
vsv
bind
pl
bilay
carneiro
et
al
entropi
term
compon
entropi
term
solvent
like
posit
disord
henc
entropi
water
solvent
molecul
displac
gpcr
contact
surfac
bind
may
increas
jmolk
antibodi
bind
antigen
bostrom
et
al
conf
neg
due
reduct
conform
mobil
estim
jmolk
per
amino
acid
order
disord
region
protein
rajasekaran
et
al
jmolk
antibodi
bind
antigen
bostrom
et
al
rt
neg
interact
particl
immobilis
surfac
jmolk
pentapeptid
bind
lipid
membran
bental
et
al
jmolk
antibodi
bind
antigen
bostrom
et
al
mem
neg
give
repuls
forc
push
viru
away
host
cell
sharma
data
overal
muc
free
f
v
eq
provid
evid
stochast
issu
also
demonstr
output
mechanist
model
appli
directli
convent
doserespons
model
three
approach
parameteris
k
set
tabl
case
k
determin
experiment
directli
measur
viru
bind
cell
tabl
approach
develop
estim
k
publish
k
valu
routin
measur
experiment
thu
magnitud
k
bind
viru
host
cell
determin
strength
interact
viral
surfac
compon
typic
viral
glycoprotein
gp
case
envelop
virus
ebov
receptor
cr
eg
tcell
immunoglobulin
mucin
domain
protein
ebov
human
host
cell
surfac
yuan
et
al
biochemist
quantifi
bind
affin
molecul
term
dissoci
constant
price
dwek
revers
dissoci
process
given
magnitud
k
unit
moldm
may
determin
experiment
purifi
part
viru
gp
host
cr
use
surfac
plasmon
reson
spr
one
protein
partner
immobil
chip
surfac
chang
refract
index
use
measur
bind
partner
free
solut
thu
yuan
et
al
immobil
ebovgp
chip
use
spr
measur
k
bind
solubl
human
solut
ebov
entri
involv
second
gpcr
bind
step
within
endosom
gp
bind
host
niemannpick
protein
use
spr
wang
et
al
report
k
ebov
gp
bind
human
bind
affin
ebov
gp
much
weaker
merscov
bind
cellular
receptor
k
measur
spr
lu
et
al
raman
et
al
summaris
k
influenza
viru
ha
bind
host
cell
glycan
human
tracheal
alveolar
section
bind
human
receptor
k
rang
other
show
k
gambaryan
et
al
present
k
bind
influenza
virus
glycan
typic
rang
singl
gpcr
interact
k
reciproc
k
howev
reciproc
k
valu
measur
spr
gpcr
interact
directli
use
k
valu
fig
k
measur
spr
take
account
number
gpcr
contact
per
viruscel
interact
also
allow
chang
entropi
bind
immobil
whole
viru
particl
cell
discuss
exampl
beniac
et
al
calcul
ebov
virion
filament
nm
length
would
copi
gp
spike
protein
could
therefor
make
multipl
contact
cr
molecul
host
cell
surfac
chang
gibb
free
energi
dissoci
one
mole
gpcr
contact
relat
k
price
dwek
kastrit
bonvin
temperatur
r
ideal
ga
constant
jmol
k
price
dwek
sinc
gibb
free
energi
g
state
function
thermodynam
overal
chang
g
dissoci
n
mole
gpcr
contact
given
sinc
chang
gibb
free
energi
associ
one
mole
viru
one
mole
cell
relat
k
g
r
l
n
k
gale
chang
gibb
free
energi
associ
n
mole
gpcr
contact
g
n
g
kastrit
bonvin
k
k
n
take
account
chang
entropi
whole
viru
bind
discuss
k
may
express
valu
g
affect
temperatur
pressur
reason
g
use
biochemist
thu
provid
temperatur
pressur
constant
assum
viru
host
intestin
chang
g
relat
chang
energi
within
system
interest
name
molecular
interact
viru
host
infect
within
simul
intestin
approach
tabl
calcul
associ
constant
k
chang
two
thermodynam
paramet
name
enthalpi
h
entropi
bind
thu
k
relat
associ
viru
cell
gale
kastrit
bonvin
accord
rearrang
give
chang
enthalpi
entropi
respect
virushost
cell
system
associ
carneiro
et
al
gale
therefor
principl
know
would
enabl
calcul
k
henc
f
c
given
dose
viru
fig
bostrom
et
al
demonstr
bind
affin
antibodi
could
broken
enthalpi
entropi
term
approach
could
appli
viru
infect
aim
calibr
doserespons
model
summar
approach
tabl
author
knowledg
data
virus
bind
host
cell
howev
carneiro
et
al
measur
forc
vesicular
stomat
viru
vsv
artifici
phospholipid
pl
bilay
oppos
host
cell
obtain
valu
kjmol
j
molk
respect
carneiro
et
al
approach
tabl
depend
estim
shown
carneiro
et
al
vsv
bind
pl
bilay
decreas
entropi
huge
tabl
demonstr
import
understand
estim
k
unlik
base
molecular
contact
bind
face
involv
chang
order
mobil
difficult
visualis
may
broken
number
compon
act
addit
bostrom
et
al
thu
solvent
chang
entropi
water
solvent
molecul
conf
chang
intern
conform
freedom
protein
rt
chang
rotat
translat
freedom
viru
mem
entrop
pressur
associ
bring
two
membran
close
togeth
exampl
viru
envelop
approach
host
cell
membran
prior
fusion
sharma
like
contribut
four
entropi
compon
term
summar
tabl
mani
ligand
bind
protein
intrins
disord
region
idr
undergo
disordertoord
transit
near
interfac
bind
ligand
fong
et
al
decreas
entropi
conf
neg
rajasekaran
et
al
viral
protein
rich
intrins
disord
dolan
et
al
intrins
disord
protein
serv
host
cell
receptor
virus
exampl
ephrin
receptor
ligand
bind
domain
fong
et
al
also
serv
receptor
hendra
viru
hev
niv
xu
et
al
thu
unbound
ephrin
receptor
contain
partial
disord
loop
complex
bound
ephrin
loop
order
form
ligandbind
channel
fong
et
al
rais
question
whether
ephrin
receptor
undergo
disordertoord
transit
hevniv
bind
interestingli
xu
et
al
show
xray
crystal
structur
bind
hev
g
protein
involv
movement
tryptophan
latch
receptor
would
chang
conform
entropi
conf
associ
format
hev
g
receptor
complex
accord
eq
increas
number
gpcr
contact
viru
bind
increas
k
henc
infect
accord
fig
counterintuit
case
ebov
gp
pseudovirus
increas
surfac
densiti
gp
actual
decreas
infect
perhap
reflect
steric
hindranc
tightli
pack
gp
protein
mohan
et
al
block
conform
chang
give
increas
conf
requir
bind
gp
gale
consist
observ
ebov
gp
well
separ
space
ebov
filament
surfac
beniac
et
al
thu
allow
plenti
space
conform
chang
without
steric
hindranc
demonstr
chang
conf
could
explain
increas
infect
report
mohan
et
al
decreas
gp
densiti
may
explor
eq
thu
increas
jmolk
irrespect
valu
increas
k
decreas
conform
entropi
conf
due
steric
hindranc
jmolk
repres
order
four
amino
acid
residu
basi
j
molk
per
residu
propos
rajasekaran
et
al
disord
protein
therefor
block
disord
four
amino
acid
ebov
gp
could
explain
decreas
infect
ebov
gp
pseudovirus
high
gp
densiti
booth
et
al
show
filoviru
filament
flexibl
flexibl
filament
paramyxovirus
much
flexibl
rhabdovirus
thu
flexibl
filament
make
multipl
gp
cr
contact
adopt
mani
conform
bound
host
cell
surfac
rigid
rod
length
bound
filament
therefor
higher
entropi
stiff
rod
higher
k
flexibl
filament
also
test
multipl
gpcr
contact
thu
maximis
contact
make
neg
magnitud
increas
k
accord
eq
inde
booth
et
al
suggest
extrem
aspect
ratio
filament
may
adapt
enhanc
cellular
attach
associ
two
speci
form
bound
complex
eg
bind
ligand
protein
adsorpt
peptid
lipid
membran
alway
involv
entropi
loss
bental
et
al
doubt
appli
bind
virus
cell
consider
rt
may
particular
import
bind
filovirus
gale
compris
repeat
modular
unit
link
togeth
singl
long
filament
beniac
et
al
booth
et
al
thu
gale
argu
prior
immobilis
multipl
viru
unit
link
togeth
polyploid
filament
enhanc
cell
bind
compar
singl
viru
unit
case
filovirus
less
unfavour
rt
term
furthermor
reason
natur
polyploid
filoviru
filament
may
bind
strongli
cell
suggest
result
experi
determin
filoviru
infect
use
ebov
gpexpress
pseudovirus
spheric
singl
use
enthalpi
relat
chang
amino
acid
sequenc
bind
face
viru
gp
host
receptor
protein
chang
k
lack
data
limit
use
approach
tabl
determin
k
eq
may
appli
determin
impact
amino
acid
chang
gp
cr
k
henc
link
genet
sequenc
data
risk
infect
ultim
aim
would
predict
sequenc
chang
affect
infect
host
rang
jump
speci
barrier
perspect
doserespons
could
includ
assess
rel
risk
novel
strain
viru
mutat
gp
also
assess
risk
standard
viru
jump
speci
barrier
novel
host
may
amino
acid
differ
cr
rel
standard
host
start
point
inform
infect
standard
viru
standard
host
also
crystal
structur
data
standard
viru
gp
bound
standard
host
cr
crystal
structur
data
avail
number
viral
gp
dock
human
host
cell
cr
atom
detail
includ
ebov
merscov
zhao
et
al
wang
et
al
lu
et
al
know
crystal
structur
gpcr
protein
complex
assist
understand
chang
amino
acid
bind
interfac
gp
cr
affect
henc
k
eq
thu
although
may
known
may
possibl
predict
chang
ie
amino
acid
substitut
basic
biophys
knowledg
energi
intermolecular
forc
hold
protein
togeth
typic
salt
bridg
hydrogen
bond
shown
merscov
bound
cr
lu
et
al
exampl
could
appli
demonstr
tabl
chang
amino
acid
involv
salt
bridg
salt
bridg
neg
charg
amino
acid
residu
one
protein
interact
electrostat
posit
charg
residu
protein
result
strong
attract
salt
bridg
eg
histidin
posit
charg
aspart
asp
neg
charg
bacteriophag
lysozym
contribut
kjmol
anderson
et
al
dong
zhou
purpos
demonstr
tabl
assum
salt
bridg
format
kjmol
give
chang
k
price
dwek
salt
bridg
remov
ad
mutat
proxim
two
residu
charg
result
electrostat
repuls
scenario
b
repres
virus
weak
affin
host
scenario
e
repres
virus
adapt
host
huge
increas
affin
scenario
e
two
mutat
away
thu
chang
two
posit
charg
amino
acid
scenario
neg
charg
amino
acid
scenario
e
could
increas
k
fold
amino
acid
chang
ebov
gp
affect
host
specif
thu
ebov
makona
west
africa
outbreak
adapt
human
becam
less
infecti
bat
substitut
alanin
valin
v
residu
gp
diehl
et
al
urbanowicz
et
al
refer
substitut
howev
chang
infect
human
measur
ebov
gp
pseudovirus
infect
human
cell
line
appear
rel
small
rang
increas
infect
due
increas
f
c
fig
would
reflect
increas
k
chang
accord
eq
kjmol
would
probabl
reflect
chang
term
sinc
residu
ebov
gp
residu
make
multipl
atom
contact
directli
six
surfac
residu
protein
wang
et
al
thu
substitut
gp
may
chang
kjmol
basi
measur
chang
infect
rel
small
chang
compar
kjmol
salt
bridg
consist
chemic
similar
alanin
valin
human
protein
cr
asp
residu
protrud
surfac
contact
ebov
gp
dock
complex
zhao
et
al
natur
presenc
phenylalanin
phe
residu
instead
asp
african
strawcolour
fruit
bat
eidolon
helvum
appear
protect
speci
ebov
ng
et
al
inde
replac
phe
residu
e
helvum
asp
complet
restor
bind
ebov
gp
ng
et
al
xray
structur
presenc
phe
residu
e
helvum
would
caus
sever
clash
bind
ebov
gp
zhao
et
al
e
helvum
gp
complex
would
significantli
less
neg
bind
human
perhap
even
posit
reflect
repuls
inde
determin
would
enabl
effect
asp
phe
substitut
residu
k
henc
infect
ebov
e
helvum
assess
eq
tabl
hoffmann
et
al
develop
vsv
pseudovirus
filoviru
gp
express
surfac
test
effici
gpmediat
cell
entri
cell
line
differ
bat
speci
hoffmann
et
al
demonstr
effici
entri
ebovgp
vsv
pseudoviru
e
helvum
cell
line
markedli
reduc
compar
gp
filovirus
standard
viru
level
infect
detect
howev
high
level
ie
undilut
viru
ebovgp
vsv
pseudoviru
show
significantli
increas
infect
compar
neg
control
thu
ebov
gp
capabl
mediat
entri
e
helvum
cell
albeit
low
effici
entir
consist
doserespons
model
simul
fig
predict
low
k
small
fraction
host
cell
bound
viru
high
viru
dose
ie
thu
infect
would
expect
e
helvum
basi
eq
probabl
infect
although
low
low
k
valu
would
never
zero
threshold
k
bind
occur
fig
support
hayman
et
al
report
ebov
antibodi
one
e
helvum
bat
test
ghana
suggest
result
ebov
infect
valu
k
mucin
may
deriv
publish
data
strength
interact
lectin
glycan
lectin
protein
bind
select
glycan
group
taylor
drickam
virus
influenza
viru
nov
rotaviru
behav
lectin
bind
select
glycan
inde
k
mucin
relat
number
lectinglycan
interact
respect
k
way
k
accord
eq
dam
brewer
report
k
lectin
soy
bean
agglutinin
bind
porcin
submaxillari
mucin
multipl
galnac
sugar
bind
similarli
vataira
macrocarpa
lectin
k
porcin
submaxillari
mucin
act
singli
ie
use
n
eq
k
would
translat
k
mucin
valu
high
excess
mucin
would
need
achiev
remov
viru
accord
fig
two
mechan
magnitud
k
mucin
could
increas
multipl
bind
interact
irrevers
bind
effect
multipl
contact
strength
bind
shown
bind
mannos
bind
protein
mbp
carbohydr
structur
surfac
pathogen
carbohydraterecognit
domain
crd
mbp
interact
termin
sugar
residu
oligosaccharid
chain
taylor
drickam
k
interact
high
mannos
oligosaccharid
ie
low
affin
highaffin
bind
mbp
requir
interact
multipl
crd
multipl
termin
mannos
residu
trimer
structur
mbp
present
cluster
crd
interact
appropri
space
termin
mannos
residu
pathogen
surfac
thu
array
termin
sugar
residu
surfac
microorgan
interact
multipl
site
tabl
theoret
consider
chang
mutat
affect
two
amino
acid
residu
involv
salt
bridg
contact
interfac
gp
cr
could
affect
bind
affin
k
k
effect
mutat
number
charg
amino
acid
residu
opposit
contact
surfac
gp
cr
represent
posit
amino
acid
residu
neg
amino
acid
residu
electrostat
neutral
amino
acid
residu
kjmol
rel
scenario
c
calcul
assum
one
salt
bridg
contribut
kjmol
anderson
et
al
effect
simultan
shown
eq
three
way
interact
involv
three
bind
site
k
result
overal
k
multival
ligand
ie
pathogen
surfac
appropri
space
termin
sugar
residu
taylor
drickam
case
influenza
viru
bind
site
ha
polypeptid
rel
shallow
interact
primarili
termin
sialic
acid
residu
link
galactos
taylor
drickam
affin
monomer
sialosid
weak
k
bind
cell
surfac
enhanc
simultan
interact
multipl
habind
site
multipl
sialic
acid
residu
target
host
cell
taylor
drickam
cumul
effect
n
bind
site
k
given
n
th
power
eq
thu
seven
interact
k
exampl
would
give
k
conclud
mucin
mbp
prr
innat
immun
system
could
bind
viru
suffici
affin
slight
mucin
excess
could
remov
viru
fig
furthermor
k
mucin
could
becom
higher
viru
irrevers
bound
exampl
fold
insid
mucou
droplet
longer
exchang
free
viru
outsid
effect
k
would
tend
eq
henc
k
mucin
would
tend
infin
note
magnitud
k
henc
k
k
mucin
constant
given
molecular
interact
given
temperatur
howev
magnitud
k
mucin
may
chang
infect
process
host
mechan
viru
mechan
discuss
mucin
glycosyl
chang
infect
mucin
isol
rotavirusinfect
mice
day
post
infect
potent
inhibit
rotaviru
infect
mucin
control
mice
boshuizen
et
al
interestingli
also
agedepend
differ
mucin
quantiti
composit
andor
structur
alter
antivir
capabl
small
intestin
mucin
boshuizen
et
al
furthermor
mucin
product
host
increas
infect
rotaviru
mucincod
mrna
level
peak
day
post
infect
boshuizen
et
al
thu
mucin
viru
ratio
magnitud
k
mucin
could
chang
progress
infect
henc
affect
f
v
fig
viral
mechan
remov
viru
mucin
increas
concentr
free
viru
exampl
case
influenza
viru
neuraminidas
remov
sialic
acid
glycan
enabl
viru
particl
remov
cell
surfac
assembl
decoy
receptor
eg
mucu
guo
et
al
two
effect
viru
bind
fig
first
increas
rate
remov
viru
k
eq
henc
decreas
k
mucin
second
decreas
concentr
mucin
thu
decreas
mucin
viru
ratio
fig
act
synergist
increas
fraction
free
viru
case
influenza
virus
ha
protein
bind
sialosid
receptor
host
cell
surfac
preferenti
bind
sialic
acid
link
penultim
galactos
guo
et
al
balanc
activ
ha
neuraminidas
protein
critic
role
optim
viral
fit
tropism
transmiss
guo
et
al
oppos
effect
ha
neuraminidas
influenza
viru
infect
could
model
effect
k
mucin
k
k
eq
mucin
viru
ratio
fig
handel
et
al
use
differenti
equat
model
sticki
influenza
viru
maxim
fit
sticki
repres
balanc
attach
detach
shanker
et
al
propos
local
flexibl
part
nov
surfac
protein
could
allow
viru
disassoci
salivari
mucinlink
hbga
chang
microenviron
ph
exampl
passag
gi
tract
subsequ
associ
hbga
link
intestin
epitheli
cell
effect
k
rate
increas
eq
k
mucin
vari
differ
part
host
concept
paper
present
gener
approach
use
data
biochemistri
molecular
biolog
parameter
doserespons
model
mra
thermodynam
equat
model
develop
host
intestin
simul
cell
volum
dm
initi
infect
process
broken
two
stage
name
escap
viru
innat
host
defens
barrier
fig
subsequ
bind
remain
viru
specif
receptor
host
cell
fig
two
paramet
name
f
v
f
c
quantifi
stage
repres
probabl
togeth
p
cell
use
eq
give
complet
doserespons
model
calcul
risk
infect
host
given
challeng
dose
v
initi
although
v
intestin
eq
appear
eq
use
fig
estim
f
c
eq
differ
equat
approach
develop
tediou
appli
mra
appli
eq
eq
would
greatli
simplifi
calcul
f
c
f
v
respect
mra
purpos
howev
use
eq
f
c
fail
low
dose
viru
high
bind
affin
host
cell
k
differ
equat
approach
use
fig
use
eq
f
v
appropri
mra
mucin
concentr
exce
viru
concentr
host
factor
k
mucin
fig
mechanist
approach
develop
may
use
determin
id
see
tabl
easi
calcul
p
risk
host
ingest
dose
one
pathogen
paramet
p
may
use
directli
convent
doserespons
model
eq
thu
link
applic
mechanist
model
develop
mra
work
appear
demonstr
stochast
mechanist
model
issu
stochast
issu
aris
low
dose
high
affin
pathogen
ie
high
k
approach
use
differ
equat
approach
determin
id
p
calcul
use
directli
eq
thu
depend
cours
valu
p
cell
cv
much
greater
id
tabl
stochast
issu
minimis
although
inform
concentr
mucin
protein
saliva
intestin
need
lack
data
thermodynam
paramet
main
limit
factor
approach
tabl
use
eq
calcul
k
limit
current
lack
data
virushost
cell
interact
approach
use
publish
k
data
therefor
pursu
absenc
experiment
k
data
approach
data
avail
k
gpcr
bind
sever
virus
approach
use
eq
estim
k
also
limit
lack
inform
bind
whole
viru
cell
import
magnitud
immobil
whole
viru
like
huge
demonstr
vsv
bind
artifici
pl
bilay
tabl
lack
inform
therefor
major
data
gap
furthermor
may
also
wider
implic
affect
abil
interpret
measur
k
valu
term
actual
infect
viru
thu
k
determin
eq
take
account
whole
viru
bind
defin
infect
see
result
tabl
k
alon
bind
whole
viru
cell
much
greater
bind
solubl
protein
fragment
k
determin
spr
inde
bind
vsv
huge
jmolk
compar
rt
conf
term
bind
antibodi
antigen
tabl
compar
gp
bind
cr
term
molecular
size
model
develop
base
eq
allow
multipl
viru
particl
bind
singl
host
cell
howev
cell
membran
host
cell
typic
contain
mani
copi
cr
theori
host
cell
could
therefor
bind
multipl
copi
viru
furthermor
viru
particl
could
ingest
clump
inde
case
ebov
mani
genom
copi
may
link
togeth
long
polyploid
filament
beniac
et
al
could
affect
thermodynam
bind
gale
eq
could
modifi
accommod
multipl
virus
bind
singl
host
cell
describ
ligand
bind
protein
price
dwek
number
cr
per
host
cell
known
stress
homogen
mucin
pathogen
assum
simplic
develop
mechanist
model
data
would
need
heterogen
mucin
concentr
also
statist
distribut
number
virus
bound
per
cell
exampl
distribut
could
poisson
ratio
viru
bound
per
host
cell
repres
high
v
intestin
host
cell
zero
one
two
three
even
four
virus
bound
altern
distribut
could
overdispers
host
cell
thousand
bound
viru
none
clearli
overdispers
would
decreas
cv
compar
poisson
distribut
model
present
demonstr
proof
principl
model
f
c
function
v
intestin
assum
host
cell
bind
one
viru
eq
appropri
two
reason
first
exposur
faecalor
pathogen
rout
water
may
involv
low
number
pathogen
per
person
see
gale
would
unlik
one
pathogen
would
bind
host
cell
second
maximis
cv
henc
p
host
thu
bind
one
viru
host
cell
may
wast
viru
resourc
cv
eq
maximis
bind
two
virus
cell
affect
p
cell
unless
cooper
two
virus
way
one
facilit
infect
sens
valu
p
host
predict
mechanist
doserespons
worst
case
note
gale
propos
format
polyploid
filament
case
ebov
inde
enhanc
cell
bind
optimis
effect
repres
cooper
viral
particl
infect
process
demonstr
import
consid
statist
distribut
aspect
viru
clump
also
thermodynam
implic
bind
shown
fig
probabl
viru
escap
mucin
barrier
repres
f
v
control
mucin
viru
ratio
mucinviru
bind
affin
repres
k
mucin
rang
k
mucin
biolog
signific
k
mucin
valu
free
viru
mucin
viru
ratio
accord
simul
fig
valu
k
mucin
could
high
due
multipl
contact
repeat
unit
fold
bound
viru
interior
mucu
read
xaxi
right
left
fig
suggest
threshold
effect
viru
dose
bind
capac
mucin
exceed
high
viru
dose
consid
interest
develop
mra
gener
assum
threshold
dose
approach
develop
fig
mucin
could
also
appli
model
probabl
viru
inactiv
compon
host
innat
immun
system
prr
includ
mbp
recogn
repeat
unit
pathogen
surfac
bound
mbp
viru
would
taken
phagocytosi
complement
system
macrophag
destroy
taylor
drickam
probabl
host
cell
bound
viru
repres
f
c
increas
linearli
dose
fig
biolog
signific
rang
k
within
f
c
increas
linearli
increas
k
fig
k
valu
measur
spr
rang
gpcr
interact
merscov
influenza
viru
suggest
strong
bind
lu
et
al
raman
et
al
even
ebov
gp
k
rang
yuan
et
al
wang
et
al
high
k
valu
could
achiev
multipl
contact
eq
although
may
offset
term
discuss
increas
k
increas
fraction
f
c
host
cell
bound
viru
fig
f
c
versu
viru
dose
curv
superimpos
fig
k
high
k
receptor
bind
like
ratelimit
infect
process
thu
xu
et
al
found
stabil
associ
strongli
correl
effici
viral
entri
suggest
cell
viral
attach
rate
limit
step
viral
entri
process
consist
highli
effici
bind
ie
larg
k
increas
k
increas
fraction
cell
bound
viru
f
c
accord
fig
henc
cv
eq
constant
ratelimit
subsequ
part
infect
process
accommod
p
cell
less
effici
f
c
p
cell
small
control
overal
valu
p
host
accord
eq
inde
magnitud
k
much
import
receptor
bind
ineffici
jump
speci
barrier
novel
host
emerg
viru
suggest
gale
confirm
fig
f
c
increas
linearli
k
lower
k
valu
gale
demonstr
viru
bind
receptor
import
control
probabl
infect
host
cell
major
barrier
ie
rel
ineffici
k
viru
jump
speci
barrier
novel
host
speci
would
expect
low
perhap
due
electrostat
repuls
scenario
b
tabl
subsequ
adapt
viru
new
host
mutat
would
increas
k
suggest
tabl
report
ebov
human
diehl
et
al
urbanowicz
et
al
magnitud
larg
control
good
molecular
fit
viru
gp
surfac
cr
surfac
depend
hydrogen
bond
salt
bridg
shown
tabl
chang
may
use
predict
chang
k
provid
molecular
basi
gpcr
interact
avail
atom
detail
enabl
assess
infect
new
viru
host
combin
rel
standard
virushost
would
directli
proport
chang
k
demonstr
result
tabl
thu
thermodynam
provid
link
chang
virushost
identifi
sequenc
data
risk
infect
theori
allow
predict
infect
emerg
viru
strain
suscept
novel
host
assess
basi
effect
chang
sequenc
data
conclud
thermodynam
approach
major
contribut
make
develop
doserespons
model
emerg
virus
none
declar
view
express
paper
author
necessarili
organis
